BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17569614)

  • 1. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential.
    Shankar S; Singh G; Srivastava RK
    Front Biosci; 2007 Sep; 12():4839-54. PubMed ID: 17569614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
    Aggarwal BB; Bhardwaj A; Aggarwal RS; Seeram NP; Shishodia S; Takada Y
    Anticancer Res; 2004; 24(5A):2783-840. PubMed ID: 15517885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.
    Shankar S; Siddiqui I; Srivastava RK
    Mol Cell Biochem; 2007 Oct; 304(1-2):273-85. PubMed ID: 17636462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of cancer and cardiovascular disease by resveratrol.
    Lin JK; Tsai SH
    Proc Natl Sci Counc Repub China B; 1999 Jul; 23(3):99-106. PubMed ID: 10492890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol and chemoprevention.
    Goswami SK; Das DK
    Cancer Lett; 2009 Oct; 284(1):1-6. PubMed ID: 19261378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol: a multitargeted agent for age-associated chronic diseases.
    Harikumar KB; Aggarwal BB
    Cell Cycle; 2008 Apr; 7(8):1020-35. PubMed ID: 18414053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target.
    Ferraz da Costa DC; Fialho E; Silva JL
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28629161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol, a natural chemopreventive agent against degenerative diseases.
    Ignatowicz E; Baer-Dubowska W
    Pol J Pharmacol; 2001; 53(6):557-69. PubMed ID: 11985329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of hepatic proinflammatory cytokines is involved in the resveratrol-mediated chemoprevention of chemically-induced hepatocarcinogenesis.
    Mbimba T; Awale P; Bhatia D; Geldenhuys WJ; Darvesh AS; Carroll RT; Bishayee A
    Curr Pharm Biotechnol; 2012 Jan; 13(1):229-34. PubMed ID: 21466437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials.
    Bishayee A
    Cancer Prev Res (Phila); 2009 May; 2(5):409-18. PubMed ID: 19401532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway.
    Singh SK; Banerjee S; Acosta EP; Lillard JW; Singh R
    Oncotarget; 2017 Mar; 8(10):17216-17228. PubMed ID: 28212547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.
    Athar M; Back JH; Kopelovich L; Bickers DR; Kim AL
    Arch Biochem Biophys; 2009 Jun; 486(2):95-102. PubMed ID: 19514131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol-mediated sensitisation to TRAIL-induced apoptosis depends on death receptor and mitochondrial signalling.
    Fulda S; Debatin KM
    Eur J Cancer; 2005 Mar; 41(5):786-98. PubMed ID: 15763656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol induces cell cycle arrest via a p53-independent pathway in A549 cells.
    Yuan L; Zhang Y; Xia J; Liu B; Zhang Q; Liu J; Luo L; Peng Z; Song Z; Zhu R
    Mol Med Rep; 2015 Apr; 11(4):2459-64. PubMed ID: 25515619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent and suppression of Akt/NF-κB signaling.
    Rasheduzzaman M; Jeong JK; Park SY
    Life Sci; 2018 Sep; 208():208-220. PubMed ID: 30031063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer.
    Delmas D; Lançon A; Colin D; Jannin B; Latruffe N
    Curr Drug Targets; 2006 Apr; 7(4):423-42. PubMed ID: 16611030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets.
    Kundu JK; Surh YJ
    Mutat Res; 2004 Nov; 555(1-2):65-80. PubMed ID: 15476852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The basis for the chemopreventive action of resveratrol.
    Roemer K; Mahyar-Roemer M
    Drugs Today (Barc); 2002 Aug; 38(8):571-80. PubMed ID: 12582422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol addiction: to die or not to die.
    Shakibaei M; Harikumar KB; Aggarwal BB
    Mol Nutr Food Res; 2009 Jan; 53(1):115-28. PubMed ID: 19072742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol induces apoptosis via a Bak-mediated intrinsic pathway in human lung adenocarcinoma cells.
    Zhang W; Wang X; Chen T
    Cell Signal; 2012 May; 24(5):1037-46. PubMed ID: 22245142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.